Zydus Pharmaceuticals (USA) Inc., the U.S. generic drug branch of Zydus Lifesciences, experienced unauthorized activity on its computer network on or around July 28, 2024. Following an investigation, Zydus determined that a data breach may have compro...
We've done the analysis so you can make the decisions
Search our repository of 6,553 high-quality, objective, peer-reviewed case studies, impacting 6,639 companies and resulting in $43,860,425,578 in net costs